Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Heatmap of prevalence of 14 high-risk medication categories by cluster.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • الموضوع:
      2025
    • نبذة مختصرة :
      Alpha-1 blockers, Peripheral alpha-1 blockers unless for benign prostatic hyperplasia; BZDs, Benzodiazepines (including ‘Z-drugs’); CCBs, Calcium channel blockers; NSAIDs, Nonsteroidal anti-inflammatory drugs; PPIs, Proton-pump inhibitors (use for >8 weeks unless high‐risk patients); RAAS, Renin angiotensin-aldosterone system. Cluster 1 = ‘None’ cluster (n = 431); Cluster 2 = ‘Calcium channel blockers (CCBs)’ cluster (n = 139); Cluster 3 = ‘Renin-angiotensin-aldosterone system (RAAS) inhibitors’ cluster (n = 174); Cluster 4 = ‘Diuretics’ cluster (n = 140); Cluster 5 = ‘Benzodiazepines (BZDs)’ cluster (n = 164).
    • الرقم المعرف:
      10.1371/journal.pone.0332210.g001
    • الدخول الالكتروني :
      https://doi.org/10.1371/journal.pone.0332210.g001
      https://figshare.com/articles/figure/Heatmap_of_prevalence_of_14_high-risk_medication_categories_by_cluster_/30106848
    • Rights:
      CC BY 4.0
    • الرقم المعرف:
      edsbas.85E5C326